{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,12,22]],"date-time":"2023-12-22T06:02:08Z","timestamp":1703224928525},"reference-count":6,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2000,1,1]],"date-time":"2000-01-01T00:00:00Z","timestamp":946684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2000,1]]},"DOI":"10.1006\/gyno.1999.5630","type":"journal-article","created":{"date-parts":[[2002,10,6]],"date-time":"2002-10-06T21:31:24Z","timestamp":1033939884000},"page":"128-129","source":"Crossref","is-referenced-by-count":10,"title":["Complete Response to Topotecan of Recurrent Fallopian Tube Carcinoma"],"prefix":"10.1006","volume":"76","author":[{"given":"Charles J.","family":"Dunton","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia","family":"Neufeld","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1006\/gyno.1999.5630_RF1","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S1055-3207(18)30276-X","article-title":"Fallopian tube carcinoma","volume":"7","author":"Nikrui","year":"1998","journal-title":"Surg Oncol Clin North Am"},{"key":"10.1006\/gyno.1999.5630_RF2","first-page":"287","article-title":"Fallopian tube cancer. Society of Gynecologic Oncologists Clinical Practice Guidelines","volume":"12","author":"Practice","year":"1998","journal-title":"Oncology"},{"key":"10.1006\/gyno.1999.5630_RF3","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.1200\/JCO.1998.16.8.2620","article-title":"Phase II trial of intraperitoneal paclitaxel in carcinoma of the ovary, tube, and peritoneum: A Gynecologic Oncology Group Study","volume":"16","author":"Markman","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1006\/gyno.1999.5630_RF4","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1200\/JCO.1998.16.5.1849","article-title":"Ninety-six-hour infusional paclitaxel as salvage therapy of ovarian cancer patients previously failing treatment with 3-hour or 24-hour paclitaxel infusion regimens","volume":"16","author":"Markman","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1006\/gyno.1999.5630_RF5","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1634\/theoncologist.4-2-87","article-title":"Extending the platinum-free interval in recurrent ovarian cancer: The role of topotecan in second-line chemotherapy","volume":"4","author":"Bookman","year":"1999","journal-title":"Oncologist"},{"key":"10.1006\/gyno.1999.5630_RF6","first-page":"S5-2","article-title":"New options for the treatment of advanced ovarian cancer","volume":"24","author":"Dunton","year":"1997","journal-title":"Semin Oncol"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825899956305?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825899956305?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,5,3]],"date-time":"2021-05-03T06:08:42Z","timestamp":1620022122000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825899956305"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,1]]},"references-count":6,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2000,1]]}},"alternative-id":["S0090825899956305"],"URL":"https:\/\/doi.org\/10.1006\/gyno.1999.5630","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2000,1]]}}}